Immune Response To Intranasal Influenza Vaccination
The Systemic And Local Immune Response To Intranasal Influenza Vaccination
Sponsor: Haukeland University Hospital
This NA trial investigates Tonsillitis, Hypertrophy and is currently ongoing. Haukeland University Hospital leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Sep 2023 — Jan 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Sep 2021 — Sep 2023 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation NA
-
Dec 2019 — Jan 2021 [monthly]
Enrolling By Invitation NA
Status: Unknown Status → Enrolling By Invitation
-
Oct 2018 — Dec 2019 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Enrolling By Invitation NA
-
Feb 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haukeland University Hospital
- University of Bergen
For direct contact, visit the study record on ClinicalTrials.gov .